Top Pharmaceuticals stocks in North America
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
ADMAADMA Biologics | $2.04bn | n/a | n/a |
CPRXCatalyst Pharmaceuticals | $1.88bn | 29.6 | n/a |
HRMYHarmony Biosciences Holdings | $1.71bn | 12.37 | n/a |
SUPNSupernus Pharmaceuticals | $1.59bn | n/a | n/a |
TAROTaro Pharmaceutical Industries | $1.59bn | 34.78 | n/a |
AVDLAvadel Pharmaceuticals | $1.59bn | n/a | n/a |
LGNDLigand Pharmaceuticals | $1.57bn | 16.52 | n/a |
TLRYTilray Brands | $1.56bn | n/a | n/a |
ANIPANI Pharmaceuticals | $1.43bn | 74.76 | n/a |
TARSTarsus Pharmaceuticals | $1.40bn | n/a | n/a |
PCRXPacira Biosciences | $1.37bn | 25.51 | n/a |
CRONCronos | CA$1.45bn | n/a | n/a |
VECTVectivBio Holding AG | $1.06bn | n/a | n/a |
COLLCollegium Pharmaceutical | $1.03bn | 19.22 | n/a |
PBAJPetro Usa | $1.00bn | n/a | n/a |
INVAInnoviva | $974.14m | 7.12 | n/a |
CLCresco Labs | CA$1.26bn | n/a | n/a |
LQDALiquidia | $921.18m | n/a | n/a |
WEEDCanopy Growth | CA$1.25bn | n/a | n/a |
OCULOcular Therapeutix | $876.67m | n/a | n/a |